Cargando…

Mutacin H-29B is identical to mutacin II (J-T8)

BACKGROUND: Streptococcus mutans produces bacteriocins named mutacins. Studies of mutacins have always been hampered by the difficulties in obtaining active liquid preparations of these substances. Some of them were found to be lantibiotics, defined as bacterial ribosomally synthesised lanthionine-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolas, Guillaume, Morency, Hélène, LaPointe, Gisèle, Lavoie, Marc C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462995/
https://www.ncbi.nlm.nih.gov/pubmed/16626493
http://dx.doi.org/10.1186/1471-2180-6-36
_version_ 1782127522672017408
author Nicolas, Guillaume
Morency, Hélène
LaPointe, Gisèle
Lavoie, Marc C
author_facet Nicolas, Guillaume
Morency, Hélène
LaPointe, Gisèle
Lavoie, Marc C
author_sort Nicolas, Guillaume
collection PubMed
description BACKGROUND: Streptococcus mutans produces bacteriocins named mutacins. Studies of mutacins have always been hampered by the difficulties in obtaining active liquid preparations of these substances. Some of them were found to be lantibiotics, defined as bacterial ribosomally synthesised lanthionine-containing peptides with antimicrobial activity. The goal of this study was to produce and characterize a new mutacin from S. mutans strain 29B, as it shows a promising activity spectrum against current human pathogens. RESULTS: Mutacin H-29B, produced by S. mutans strain 29B, was purified by successive hydrophobic chromatography from a liquid preparation consisting of cheese whey permeate (6% w/v) supplemented with yeast extract (2%) and CaCO(3 )(1%). Edman degradation revealed 24 amino acids identical to those of mutacin II (also known as J-T8). The molecular mass of the purified peptide was evaluated at 3246.08 ± 0.1 Da by MALDI-TOF MS. CONCLUSION: A simple procedure for production and purification of mutacins along with its characterization is presented. Our results show that the amino acid sequence of mutacin H-29B is identical to the already known mutacin II (J-T8) over the first 24 residues. S. mutans strains of widely different origins may thus produce very similar bacteriocins.
format Text
id pubmed-1462995
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14629952006-05-18 Mutacin H-29B is identical to mutacin II (J-T8) Nicolas, Guillaume Morency, Hélène LaPointe, Gisèle Lavoie, Marc C BMC Microbiol Research Article BACKGROUND: Streptococcus mutans produces bacteriocins named mutacins. Studies of mutacins have always been hampered by the difficulties in obtaining active liquid preparations of these substances. Some of them were found to be lantibiotics, defined as bacterial ribosomally synthesised lanthionine-containing peptides with antimicrobial activity. The goal of this study was to produce and characterize a new mutacin from S. mutans strain 29B, as it shows a promising activity spectrum against current human pathogens. RESULTS: Mutacin H-29B, produced by S. mutans strain 29B, was purified by successive hydrophobic chromatography from a liquid preparation consisting of cheese whey permeate (6% w/v) supplemented with yeast extract (2%) and CaCO(3 )(1%). Edman degradation revealed 24 amino acids identical to those of mutacin II (also known as J-T8). The molecular mass of the purified peptide was evaluated at 3246.08 ± 0.1 Da by MALDI-TOF MS. CONCLUSION: A simple procedure for production and purification of mutacins along with its characterization is presented. Our results show that the amino acid sequence of mutacin H-29B is identical to the already known mutacin II (J-T8) over the first 24 residues. S. mutans strains of widely different origins may thus produce very similar bacteriocins. BioMed Central 2006-04-20 /pmc/articles/PMC1462995/ /pubmed/16626493 http://dx.doi.org/10.1186/1471-2180-6-36 Text en Copyright © 2006 Nicolas et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Nicolas, Guillaume
Morency, Hélène
LaPointe, Gisèle
Lavoie, Marc C
Mutacin H-29B is identical to mutacin II (J-T8)
title Mutacin H-29B is identical to mutacin II (J-T8)
title_full Mutacin H-29B is identical to mutacin II (J-T8)
title_fullStr Mutacin H-29B is identical to mutacin II (J-T8)
title_full_unstemmed Mutacin H-29B is identical to mutacin II (J-T8)
title_short Mutacin H-29B is identical to mutacin II (J-T8)
title_sort mutacin h-29b is identical to mutacin ii (j-t8)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462995/
https://www.ncbi.nlm.nih.gov/pubmed/16626493
http://dx.doi.org/10.1186/1471-2180-6-36
work_keys_str_mv AT nicolasguillaume mutacinh29bisidenticaltomutaciniijt8
AT morencyhelene mutacinh29bisidenticaltomutaciniijt8
AT lapointegisele mutacinh29bisidenticaltomutaciniijt8
AT lavoiemarcc mutacinh29bisidenticaltomutaciniijt8